Buchang Pharmaceutical announced that Tonghua Guhong, a wholly-owned subsidiary of the company, signed a “Technology Transfer Contract” with Jilin Tiantai Pharmaceutical Co., Ltd. to transfer production approval and technical ownership of Angong Niuhuang pills for RMB 9.4 million, including all technical data such as prescriptions, production processes, and quality standards. This matter has been reviewed and approved by the 57th meeting of the 5th board of directors of the company, and there is no need to submit it to the shareholders' meeting for review and approval.

Buchang Pharmaceutical announced that Tonghua Guhong, a wholly-owned subsidiary of the company, signed a “Technology Transfer Contract” with Jilin Tiantai Pharmaceutical Co., Ltd. to transfer production approval and technical ownership of Angong Niuhuang pills for RMB 9.4 million, including all technical data such as prescriptions, production processes, and quality standards. This matter has been reviewed and approved by the 57th meeting of the 5th board of directors of the company, and there is no need to submit it to the shareholders' meeting for review and approval.